Low vitamin D linked to higher risk of renal disease in lupus

November 5, 2017, American College of Rheumatology

Low levels of vitamin D were associated with higher rates of end-stage renal disease in patients with systemic lupus erythematosus, or lupus, according to new research findings presented this week at the 2017 ACR/ARHP Annual Meeting in San Diego.

Lupus is a chronic (long-term) inflammatory autoimmune disease in which an unknown trigger causes the body's immune system to attack its own healthy tissues. The most common type of lupus is (SLE), a complex, multiple symptom autoimmune disease that can cause inflammation, pain and damage to various parts of the body. While anyone can develop lupus, it occurs 9-10 times more often in women than in men and is 2-3 times more common among women of color.

To clarify the role D levels may play in lupus inflammation, a group of researchers at Johns Hopkins University School of Medicine in Baltimore, Maryland, conducted a study to determine how low vitamin D levels could predict later . Low levels, defined as insufficiency or deficiency, of vitamin D is a common problem for patients with SLE. Some evidence suggests that vitamin D replacement therapy may help improve renal disease activity.

The researchers analyzed data on 1,392 SLE patients, including their first medical office visit where vitamin D levels were measured, and then their organ or tissue damage on all of the patient's follow-up clinic visits. The patients included in this study were 92 percent female, had a mean age of 47.3 years, and were 50 percent Caucasian and 41 percent African-American.

Patients were categorized based on 25-hydroxy vitamin D levels that were either below 20 nanograms (ng) per milliliter (ml), or at or above 20 ng/ml on their first office visit. At their first office visit where vitamin D levels were measured, 27.3 percent of the patients had levels below 20 ng/ml.

The researchers then calculated the risk of lifetime organ damage for patients with low vitamin D levels using the Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index scoring system. Organ damage rates were also adjusted for age, gender and ethnicity.

"We have shown that supplementing vitamin D reduces urine protein, which is the best predictor of future renal failure," said Michelle A. Petri, MD, PhD, Director, Hopkins Lupus Center and a lead author of the study.

According to the study's results, the relative risk of renal damage was the highest for SLE patients whose vitamin D levels were insufficient, or a relative risk of 1.87 (1.66 adjusted). Skin damage was another concern, with a relative risk of 1.69 (1.22 adjusted). Total organ damage relative risk was 1.11 (1.17 adjusted). Other long-term outcomes measured included ocular, neuropsychiatric, pulmonary, cardiovascular, gastrointestinal and musculoskeletal, but the relative risk of damage to these organ systems was not significant. There was no association between low vitamin D and musculoskeletal damage, including osteoporotic fractures, in the study.

The researchers concluded low vitamin D is associated with a higher risk of total organ and with end-stage renal disease for patients with lupus.

"Supplementary vitamin D is very safe," said Dr. Petri. "It helps to prevent one of the most dreaded complications of SLE, and likely has a role in preventing blood clots and cardiovascular as well. Vitamin D supplementation, which can reduce proteinuria, should be a part of the treatment plan for lupus nephritis ."

This research was supported by funding from the NIH's National Institute of Arthritis and Musculoskeletal and Skin Diseases.

Explore further: Low vitamin D levels linked to lupus

Related Stories

Low vitamin D levels linked to lupus

April 30, 2015
Monash-led research has shown for the first time that low vitamin D levels are associated with higher disease activity in Australian lupus patients.

Obesity linked with depressive symptoms, increased disease activity in women with lupus

November 5, 2017
Obesity is independently associated with worse patient-reported outcomes in women with systemic lupus erythematosus, including disease activity, depressive symptoms, pain and fatigue, according to new research findings presented ...

Predictors of organ damage identified in patients with SLE

December 16, 2012
(HealthDay)—Patient age, hypertension, and corticosteroid use are the most important predictors of the cumulative organ damage that occurs in patients with systemic lupus erythematosus (SLE), according to research published ...

When too much sun is not enough

May 7, 2012
(Medical Xpress) -- Lupus patients show more severe symptoms of the disease if their vitamin D levels are low, an Australian-first study has found.

Vitamin D shows no impact on interferon response in SLE

July 10, 2015
(HealthDay)—For patients with systemic lupus erythematosus (SLE), vitamin D3 supplementation does not affect interferon (IFN) signature, according to a study published in the July issue of Arthritis & Rheumatology.

Lower mortality rates among Asian and Hispanic lupus patients

January 15, 2015
A new study by researchers from Brigham and Women's Hospital in Boston, Massachusetts reveals that Asian and Hispanic patients with systemic lupus erythematosus (SLE) have lower mortality rates compared to Black, White, or ...

Recommended for you

How drug resistant TB evolved and spread globally

October 17, 2018
The most common form of Mycobacterium tuberculosis (TB) originated in Europe and spread to Asia, Africa and the Americas with European explorers and colonialists, reveals a new study led by UCL and the Norwegian Institute ...

Researchers cure drug-resistant infections without antibiotics

October 17, 2018
Biochemists, microbiologists, drug discovery experts and infectious disease doctors have teamed up in a new study that shows antibiotics are not always necessary to cure sepsis in mice. Instead of killing causative bacteria ...

Infectious disease consultation significantly reduces mortality of patients with bloodstream yeast infections

October 17, 2018
In a retrospective cohort study conducted at the University of Alabama at Birmingham Division of Infectious Diseases, patients with candidemia—a yeast infection in the bloodstream—had more positive outcomes as they relate ...

Marker may help target treatments for Crohn's patients

October 16, 2018
Crohn's disease (CD), a chronic inflammatory condition of the intestinal tract, has emerged as a global disease, with rates steadily increasing over the last 50 years. Experts have long suspected that CD likely represents ...

Study traces hospital-acquired bloodstream infections to patients' own bodies

October 15, 2018
The most common source of a bloodstream infection acquired during a hospital stay is not a nurse's or doctor's dirty hands, or another patient's sneeze or visitor's cough, but the patient's own gut, Stanford University School ...

Polio: Environmental monitoring will be key as world reaches global eradication

October 15, 2018
Robust environmental monitoring should be used as the world approaches global eradication of polio, say University of Michigan researchers who recently studied the epidemiology of the 2013 silent polio outbreak in Rahat, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.